TGA Approval

PIQRAY alpelisib 300 mg daily dose blister (150 mg tablet) (315064)

ARTG ID

315064

ARTG Name

PIQRAY alpelisib 300 mg daily dose blister (150 mg tablet)

Sponsor

Novartis Pharmaceuticals Australia Pty Ltd

ARTG Date

March 20, 2020

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

Novartis Pharmaceuticals Australia Pty Ltd.

https://medical-cdn.nocode.com/drug_tga/eed3c978a3eb97bc88a273c287882d72.pdf

https://medical-cdn.nocode.com/drug_tga/f3fd71fa20944ddd5abbf10be22f3f3c.pdf

Ingredient Name

alpelisib

Empowering clinical research with data-driven insights and AI-powered tools.

PIQRAY alpelisib 300 mg daily dose blister (150 mg tablet) (315064) - TGA 批准文号 | MedPath